Methods for the use of a PD-1 x CTLA-4 bispecific molecule

NZ835372APending Publication Date: 2026-07-31MACROGENICS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
NZ835372
Authority / Receiving Office
NZ · NZ
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-07-07
Filing Date
2021-07-23
Publication Date
2026-07-31

Smart Images

  • Figure 00000074_0000
    Figure 00000074_0000
  • Figure 00000075_0000
    Figure 00000075_0000
  • Figure 00000075_0001
    Figure 00000075_0001
Patent Text Reader

Abstract

The present invention is directed in part to dosing regimens for administering a PD-1 x CTLA-4 bispecific molecule for the treatment of cancer, and other conditions. The invention is directed in part to the use of such molecules, and to the use of pharmaceutical compositions and pharmaceutical kits that contain such molecules and that facilitate the use of such dosing regimens in the treatment of cancer or to stimulate immune cells.
Need to check novelty before this filing date? Find Prior Art